{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:02:16Z","timestamp":1756339336205,"version":"3.44.0"},"reference-count":3,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:p>Effect of intensive glucose control on microvascular events in people with type 2 diabetes \u25cf Febrile seizures in children: benefits and risks of prophylactic drug management More on gastric acid suppression and <jats:italic>C difficile<\/jats:italic> risk \u25cf What next for the cardiovascular polypill? \u25cf EMA recommends suspension of some generic drugs \u25cf Phototherapy for vitiligo \u25cf WHO targets medication-related errors<\/jats:p>","DOI":"10.1136\/dtb.2017.6.0483","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T20:40:24Z","timestamp":1496263224000},"page":"62.1-62","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of intensive glucose control on microvascular events in people with type 2 diabetes"],"prefix":"10.1136","volume":"55","member":"239","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"key":"2025082623232828000_55.6.62.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2006.03.001"},{"key":"2025082623232828000_55.6.62.2","unstructured":"Chatterjee S et al. Type 2 diabetes. Lancet [Epub ahead of print] 9 February 2017; DOI:10.1016\/ S0140-6736(17)30058-2."},{"key":"2025082623232828000_55.6.62.3","doi-asserted-by":"crossref","unstructured":"Zoungas S et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet [Epub ahead of print] 29 March 2017; DOI: 10.1016\/s2213-8587(17)30104-3.","DOI":"10.1016\/S2213-8587(17)30104-3"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2017.6.0483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:23:40Z","timestamp":1756275820000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2017.6.0483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,31]]},"references-count":3,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,7]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1136\/dtb.2017.6.0483"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2017.6.0483","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2017,5,31]]}}}